Summary of definitions, data and data sources used relating to diagnosis and management of the six CVD high risk conditions
CVD high risk conditions | Diagnosis | Management | |||
Condition | Definition in analysis | Total estimated prevalence* | Current diagnosed prevalence* | Proportion currently diagnosed† | CVD risk management interventions‡ |
High cholesterol/ QRISK≥10% | 10 year QRISK2 score ≥10% or familial hypercholesterolaemia | 34%19 | No data found | 11%§9 | Lipid modification therapy; antihypertensives; anticoagulants; weight management; smoking cessation; blood pressure self-monitoring; medicines use review |
Hypertension | BP ≥140/90 or 140/80 with diabetes or 130/80 with diabetes and chronic kidney disease or microvascular disease | 28%34 | 17%36 | 60% | Antihypertensives; weight management; smoking cessation; blood pressure self-monitoring; medicines use review |
Atrial fibrillation | Atrial fibrillation | 3%35 | 2.3%36 | 76% | Anticoagulants; weight management; smoking cessation; medicines use review |
Diabetes | Type 1 diabetes | 0.6%19 | 0.6% | 100%¶ | Lipid modification therapy; antihypertensives; blood glucose lowering medication; structured diabetes education; weight management; smoking cessation; insulin pump; blood pressure self monitoring; medicines use review |
Type 2 diabetes | 7.8%32 | 6.0%36 | 78% | ||
Combined | 8.4% | 6.6% | 78% | ||
Non-diabetic hyperglycaemia | HbA1c 6%–6.5% (42–48 mmol/mol) | 11%19 | 1.2%32 | 11% | Diabetes prevention programme; weight management; smoking cessation |
Chronic kidney disease | Chronic kidney disease stage 3a and above | 6%33 | 4%36 | 65% | Antihypertensives; weight management; individualised nutritional advice; smoking cessation; blood pressure self monitoring; medicines use review |
*Prevalence in England for individuals aged 16 and over.
†Calculated as diagnosed prevalence/total estimated prevalence.
‡Note that some of these have additional eligibility criteria, for example, only smokers eligible for smoking cessation; only overweight/obese eligible for weight management; blood pressure criteria for antihypertensives etc.
§Of patients with a recorded QRISK score. Assumes that recording of QRISK score is independent of value.
¶Assumed that all individuals with type 1 diabetes are diagnosed.
CVD, cardiovascular disease.